tradingkey.logo

MiMedx Group Inc

MDXG
5.150USD
+0.120+2.39%
Fechamento 02/06, 16:00ETCotações atrasadas em 15 min
762.59MValor de mercado
18.61P/L TTM

MiMedx Group Inc

5.150
+0.120+2.39%

Mais detalhes de MiMedx Group Inc Empresa

MiMedx Group, Inc. is a placental biologics company focused on providing a portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. Its product portfolio categories include Wound Care and Surgical. The Wound Care products include EPIFIX and EPIEFFECT, which are marketed for external use, such as in advanced wound care applications. Its EPICORD, EPICORD Expandable and EPIEFFECT product lines also offer an alternative treatment option to address larger, deeper wounds. Its Surgical and Other product offering includes AMNIOFIX and AMNIOEFFECT, which are used in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery and multiple orthopedic repairs and reconstructions. It also offers HELIOGEN, an advanced bovine collagen matrix containing type I and type III collagen that is intended for the management of moderately to heavily exudating wounds and to control minor bleeding.

Informações de MiMedx Group Inc

Código da empresaMDXG
Nome da EmpresaMiMedx Group Inc
Data de listagemAug 20, 2007
CEOCapper (Joseph H)
Número de funcionários837
Tipo de títulosOrdinary Share
Fim do ano fiscalAug 20
Endereço1775 W Oak Commons Court, Ne
CidadeMARIETTA
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal30062
Telefone17706519100
Sitehttps://mimedx.com/
Código da empresaMDXG
Data de listagemAug 20, 2007
CEOCapper (Joseph H)

Executivos da empresa MiMedx Group Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Joseph H. (Joe) Capper
Mr. Joseph H. (Joe) Capper
Chief Executive Officer, Director
Chief Executive Officer, Director
529.53K
+200000.00%
Mr. James L. Bierman
Mr. James L. Bierman
Independent Director
Independent Director
212.77K
+28609.00%
Ms. Ricci S. Whitlow
Ms. Ricci S. Whitlow
Executive Vice President, Chief Operating Officer
Executive Vice President, Chief Operating Officer
190.25K
-253782.00%
Dr. Cato T. Laurencin, M.D., Ph.D.
Dr. Cato T. Laurencin, M.D., Ph.D.
Independent Director
Independent Director
181.92K
+28609.00%
Ms. Dorothy E. Puhy
Ms. Dorothy E. Puhy
Independent Director
Independent Director
57.60K
+28609.00%
Ms. Kimberly (Kim) Maersk-Moller
Ms. Kimberly (Kim) Maersk-Moller
Chief Commercial Officer
Chief Commercial Officer
30.74K
-58300.00%
Mr. William Frank (Butch) Hulse, IV
Mr. William Frank (Butch) Hulse, IV
Chief Administrative Officer, General Counsel
Chief Administrative Officer, General Counsel
--
--
Dr. M. Kathleen Behrens Wilsey, Ph.D.
Dr. M. Kathleen Behrens Wilsey, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. K. Todd Newton
Mr. K. Todd Newton
Independent Director
Independent Director
--
--
Marty Sutter ,
Marty Sutter ,
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Joseph H. (Joe) Capper
Mr. Joseph H. (Joe) Capper
Chief Executive Officer, Director
Chief Executive Officer, Director
529.53K
+200000.00%
Mr. James L. Bierman
Mr. James L. Bierman
Independent Director
Independent Director
212.77K
+28609.00%
Ms. Ricci S. Whitlow
Ms. Ricci S. Whitlow
Executive Vice President, Chief Operating Officer
Executive Vice President, Chief Operating Officer
190.25K
-253782.00%
Dr. Cato T. Laurencin, M.D., Ph.D.
Dr. Cato T. Laurencin, M.D., Ph.D.
Independent Director
Independent Director
181.92K
+28609.00%
Ms. Dorothy E. Puhy
Ms. Dorothy E. Puhy
Independent Director
Independent Director
57.60K
+28609.00%
Ms. Kimberly (Kim) Maersk-Moller
Ms. Kimberly (Kim) Maersk-Moller
Chief Commercial Officer
Chief Commercial Officer
30.74K
-58300.00%

Detalhamento da receita

Moeda: USDAtualizado em: ter, 6 de jan
Moeda: USDAtualizado em: ter, 6 de jan
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
Por EmpresaUSD
Nome
Receita
Proporção
Advanced Wound Care
77.10M
67.79%
Surgical
36.63M
32.21%
Os dados relevantes ainda não foram divulgados pela empresa.
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Advanced Wound Care
77.10M
67.79%
Surgical
36.63M
32.21%

Distribuição de ações

Atualizado em: dom, 16 de nov
Atualizado em: dom, 16 de nov
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
EW Healthcare Partners
19.04%
BlackRock Institutional Trust Company, N.A.
5.90%
Trigran Investments, Inc.
5.20%
The Vanguard Group, Inc.
4.83%
First Light Asset Management, LLC
2.47%
Outro
62.56%
Investidores
Investidores
Proporção
EW Healthcare Partners
19.04%
BlackRock Institutional Trust Company, N.A.
5.90%
Trigran Investments, Inc.
5.20%
The Vanguard Group, Inc.
4.83%
First Light Asset Management, LLC
2.47%
Outro
62.56%
Tipos de investidores
Investidores
Proporção
Investment Advisor/Hedge Fund
19.08%
Investment Advisor
19.07%
Venture Capital
19.04%
Hedge Fund
11.72%
Research Firm
2.14%
Individual Investor
1.79%
Pension Fund
0.61%
Bank and Trust
0.33%
Insurance Company
0.03%
Outro
26.20%

Participação acionária institucional

Atualizado em: qui, 1 de jan
Atualizado em: qui, 1 de jan
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q4
455
106.79M
72.11%
-3.01M
2025Q3
443
104.90M
70.83%
-3.83M
2025Q2
451
106.45M
71.95%
-3.98M
2025Q1
460
106.92M
72.40%
-5.30M
2024Q4
455
107.57M
73.21%
-3.01M
2024Q3
429
103.18M
70.48%
-6.90M
2024Q2
424
100.59M
68.44%
-3.52M
2024Q1
405
106.53M
74.65%
+1.42M
2023Q4
391
100.91M
86.85%
+27.80M
2023Q3
385
72.00M
62.20%
-22.83M
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
EW Healthcare Partners
28.20M
19.04%
--
--
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
8.73M
5.9%
-75.29K
-0.85%
Sep 30, 2025
Trigran Investments, Inc.
7.70M
5.2%
-689.43K
-8.22%
Sep 30, 2025
The Vanguard Group, Inc.
6.78M
4.58%
-155.61K
-2.24%
Sep 30, 2025
First Light Asset Management, LLC
3.65M
2.47%
+1.73M
+89.52%
Sep 30, 2025
State Street Investment Management (US)
3.59M
2.43%
+128.69K
+3.71%
Sep 30, 2025
Geode Capital Management, L.L.C.
2.84M
1.92%
+789.00
+0.03%
Sep 30, 2025
Paradigm Capital Management, Inc.
2.65M
1.79%
-1.80M
-40.45%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
2.38M
1.61%
+99.08K
+4.34%
Sep 30, 2025
Cannell Capital, LLC
2.01M
1.36%
-60.09K
-2.90%
Sep 30, 2025
Ver Mais

ETFs Relacionados

Atualizado em: ter, 2 de dez
Atualizado em: ter, 2 de dez
Nome
Proporção
Invesco NASDAQ Future Gen 200 ETF
0.58%
Janus Henderson Small Cap Growth Alpha ETF
0.56%
First Trust Small Cap Growth AlphaDEX Fund
0.3%
iShares Micro-Cap ETF
0.17%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.16%
Franklin US Small Cap Multifactor Index ETF
0.15%
Vanguard US Quality Factor ETF
0.14%
WisdomTree US SmallCap Quality Growth Fund
0.14%
VictoryShares Small Cap Free Cash Flow ETF
0.12%
State Street SPDR S&P Biotech ETF
0.12%
Ver Mais
Invesco NASDAQ Future Gen 200 ETF
Proporção0.58%
Janus Henderson Small Cap Growth Alpha ETF
Proporção0.56%
First Trust Small Cap Growth AlphaDEX Fund
Proporção0.3%
iShares Micro-Cap ETF
Proporção0.17%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proporção0.16%
Franklin US Small Cap Multifactor Index ETF
Proporção0.15%
Vanguard US Quality Factor ETF
Proporção0.14%
WisdomTree US SmallCap Quality Growth Fund
Proporção0.14%
VictoryShares Small Cap Free Cash Flow ETF
Proporção0.12%
State Street SPDR S&P Biotech ETF
Proporção0.12%

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Data ex-dividendo
Tipo
Proporção
Sem dados
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
KeyAI